Clinical trial
Phase II Protocol of Low-Dose Whole Thorax Megavoltage Radiotherapy for Patients With SARS-COV-2 Pneumonia
NCT04466683 is registered in ClinicalTrials.gov with Ohio State University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase II Protocol of Low-Dose Whole Thorax Megavoltage Radiotherapy for Patients With SARS-COV-2 Pneumonia
- Lead sponsor
- Ohio State University
- Phase
- Phase 2
- Overall status
- Active, not recruiting
- Start date
- August 28, 2020
- Completion date
- December 31, 2026
- Enrollment
- 37 (actual)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.